Patent ID: 9029371
Filing Date: 2015-05-12
Classification: A61K,A61P,C07D

Abstract:
1. A compound of the formula (I) or a pharmaceutically acceptable salt, solvate, or hydrate thereof, wherein R1 is selected from: A is selected from the group consisting of —CO—, —NH—, —O—, —S—, —SO—, and —SO2-; ring structure B optionally contains one nitrogen atom; R2 is selected from the group consisting of H, a (1-4C) alkyl group optionally substituted with at least one fluoro atom, a (1-4C) alkoxy group optionally substituted with at least one fluoro atom, and a halogen atom; R3 is selected from the group consisting of a (1-4C)alkylene-R6 group wherein the alkylene group may be substituted with (CH R4 is selected from the group consisting of H and a (1-4C)alkyl group; R5 is at least one substituent wherein each substituent is independently selected from the group consisting of H, a (1-4C)alkyl group, and an oxo group; and W is —O—; with the proviso that the compound of formula (I) is not 2-[4-(4-chlorophenoxy)-2-chloro-phenyl]-4-morpholineethanol.